miR-346 was reported to downregulate the expression of the vitamin D receptor, glycogen synthase kinase 3 beta (GSK3B), to increase the level of ATG16L1 in colon biopsy samples of IBD patients 62. This evidence concerns the gene GSK3B and inflammatory bowel disease.